respiratory system
|
• less protein leakage into bronchoalveolar lavage fluid after lipopolysaccharide inhalation
|
immune system
|
• keratinocyte derived cytokine levels in lungs are unaffected by low doses of lipopolysaccharide
• macrophage inflammatory protein-2 levels in lungs are unaffected by low doses of lipopolysaccharide
|
|
• Il-6 levels in lungs are unaffected by low doses of lipopolysaccharide
|
|
• TNF alpha levels in lungs are unaffected by low doses of lipopolysaccharide
|
skeleton
|
• greater mineral content
|
|
• increased bone area of the tibia
|
|
• bones resistant to fracture
|
homeostasis/metabolism
|
• less protein leakage into bronchoalveolar lavage fluid after lipopolysaccharide inhalation
|
|
• keratinocyte derived cytokine levels in lungs are unaffected by low doses of lipopolysaccharide
• macrophage inflammatory protein-2 levels in lungs are unaffected by low doses of lipopolysaccharide
|
|
• Il-6 levels in lungs are unaffected by low doses of lipopolysaccharide
|
|
• TNF alpha levels in lungs are unaffected by low doses of lipopolysaccharide
|
adipose tissue
growth/size/body


Analysis Tools